Treace Medical Concepts, Inc.
Bryan Trebing has a diverse and extensive work experience in finance and management roles. Bryan currently serves as the Finance Director at Treace Medical Concepts, Inc. starting from December 2022. Prior to this, Bryan was with Medtronic, where they held the position of Finance Director and Senior Manager Finance from September 2020 to present and from April 2017 to September 2020, respectively. Before joining Medtronic, Bryan worked at NextEra Energy: FPL FiberNet, LLC as the Manager of Pricing & Project Valuation from September 2015 to April 2017. Their responsibilities included strategy and project valuation, pricing, market research, and team management. Bryan also has experience working at Lockheed Martin Corporation, where they held various financial analyst and pricing lead roles from August 2008 to September 2015.
Bryan Trebing completed their Bachelor's Degree in Finance from the University of Central Florida, where they studied from 2004 to 2008. Following their undergraduate studies, they pursued a Master of Business Administration (M.B.A.) in Business Administration and Management at Stetson University from 2009 to 2011. In addition to these degrees, they attended the University of Central Florida for an unspecified period of time, although it is unclear whether they obtained another degree or completed a different field of study during this time.
This person is not in any offices
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.